vs
Esperion Therapeutics, Inc.（ESPR）与RESOURCES CONNECTION, INC.（RGP）财务数据对比。点击上方公司名可切换其他公司
Esperion Therapeutics, Inc.的季度营收约是RESOURCES CONNECTION, INC.的1.4倍（$168.4M vs $117.7M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs -19.2%），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs -11.8%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
RGP原名 Resources Global Professionals，是 Resources Connection, Inc. 的核心运营主体，面向全球客户提供多领域专业咨询服务，覆盖财务会计、信息管理、治理风险合规、人力资本、法务监管、企业咨询与重组、战略传播以及供应链管理等板块。
ESPR vs RGP — 直观对比
营收规模更大
ESPR
是对方的1.4倍
$117.7M
营收增速更快
ESPR
高出162.9%
-19.2%
两年增速更快
ESPR
近两年复合增速
-11.8%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $117.7M |
| 净利润 | — | $-12.7M |
| 毛利率 | — | 37.1% |
| 营业利润率 | 50.6% | -10.3% |
| 净利率 | — | -10.8% |
| 营收同比 | 143.7% | -19.2% |
| 净利润同比 | — | 81.6% |
| 每股收益（稀释后） | $0.32 | $-0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRRGP
| Q4 25 | $168.4M | $117.7M | ||
| Q3 25 | $87.3M | $120.2M | ||
| Q2 25 | $82.4M | $139.3M | ||
| Q1 25 | $65.0M | $129.4M | ||
| Q4 24 | $69.1M | $145.6M | ||
| Q3 24 | $51.6M | $136.9M | ||
| Q2 24 | $73.8M | $148.2M | ||
| Q1 24 | $137.7M | $151.3M |
净利润ESPRRGP
| Q4 25 | — | $-12.7M | ||
| Q3 25 | $-31.3M | $-2.4M | ||
| Q2 25 | $-12.7M | $-73.3M | ||
| Q1 25 | $-40.5M | $-44.1M | ||
| Q4 24 | — | $-68.7M | ||
| Q3 24 | $-29.5M | $-5.7M | ||
| Q2 24 | $-61.9M | $10.5M | ||
| Q1 24 | $61.0M | $2.5M |
毛利率ESPRRGP
| Q4 25 | — | 37.1% | ||
| Q3 25 | — | 39.5% | ||
| Q2 25 | — | 40.2% | ||
| Q1 25 | — | 35.1% | ||
| Q4 24 | — | 38.5% | ||
| Q3 24 | — | 36.5% | ||
| Q2 24 | — | 40.2% | ||
| Q1 24 | — | 37.0% |
营业利润率ESPRRGP
| Q4 25 | 50.6% | -10.3% | ||
| Q3 25 | -11.4% | -1.7% | ||
| Q2 25 | 8.6% | -47.0% | ||
| Q1 25 | -34.0% | -38.4% | ||
| Q4 24 | -6.4% | -52.7% | ||
| Q3 24 | -31.0% | -3.5% | ||
| Q2 24 | 3.5% | 7.6% | ||
| Q1 24 | 52.5% | 2.8% |
净利率ESPRRGP
| Q4 25 | — | -10.8% | ||
| Q3 25 | -35.9% | -2.0% | ||
| Q2 25 | -15.4% | -52.6% | ||
| Q1 25 | -62.2% | -34.0% | ||
| Q4 24 | — | -47.2% | ||
| Q3 24 | -57.2% | -4.2% | ||
| Q2 24 | -83.9% | 7.1% | ||
| Q1 24 | 44.3% | 1.7% |
每股收益（稀释后）ESPRRGP
| Q4 25 | $0.32 | $-0.38 | ||
| Q3 25 | $-0.16 | $-0.07 | ||
| Q2 25 | $-0.06 | $-2.21 | ||
| Q1 25 | $-0.21 | $-1.34 | ||
| Q4 24 | $-0.14 | $-2.08 | ||
| Q3 24 | $-0.15 | $-0.17 | ||
| Q2 24 | $-0.33 | $0.31 | ||
| Q1 24 | $0.34 | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $89.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-302.0M | $194.6M |
| 总资产 | $465.9M | $289.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ESPRRGP
| Q4 25 | $167.9M | $89.8M | ||
| Q3 25 | $92.4M | $77.5M | ||
| Q2 25 | $86.1M | $86.1M | ||
| Q1 25 | $114.6M | $72.5M | ||
| Q4 24 | $144.8M | $78.2M | ||
| Q3 24 | $144.7M | $89.6M | ||
| Q2 24 | $189.3M | $108.9M | ||
| Q1 24 | $226.6M | $113.8M |
股东权益ESPRRGP
| Q4 25 | $-302.0M | $194.6M | ||
| Q3 25 | $-451.4M | $206.4M | ||
| Q2 25 | $-433.5M | $207.1M | ||
| Q1 25 | $-426.2M | $277.8M | ||
| Q4 24 | $-388.7M | $325.7M | ||
| Q3 24 | $-370.2M | $407.2M | ||
| Q2 24 | $-344.2M | $418.8M | ||
| Q1 24 | $-294.3M | $414.9M |
总资产ESPRRGP
| Q4 25 | $465.9M | $289.3M | ||
| Q3 25 | $364.0M | $287.2M | ||
| Q2 25 | $347.1M | $304.7M | ||
| Q1 25 | $324.0M | $375.6M | ||
| Q4 24 | $343.8M | $424.9M | ||
| Q3 24 | $314.1M | $512.9M | ||
| Q2 24 | $352.3M | $510.9M | ||
| Q1 24 | $373.1M | $523.2M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | $15.9M |
| 自由现金流经营现金流 - 资本支出 | — | $15.6M |
| 自由现金流率自由现金流/营收 | — | 13.2% |
| 资本支出强度资本支出/营收 | 0.0% | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $24.3M |
8季度趋势，按日历期对齐
经营现金流ESPRRGP
| Q4 25 | $45.2M | $15.9M | ||
| Q3 25 | $-4.3M | $-7.8M | ||
| Q2 25 | $-31.4M | $16.8M | ||
| Q1 25 | $-22.6M | $659.0K | ||
| Q4 24 | $-35.0M | $1.8M | ||
| Q3 24 | $-35.3M | $-309.0K | ||
| Q2 24 | $-7.2M | $3.2M | ||
| Q1 24 | $53.8M | $20.5M |
自由现金流ESPRRGP
| Q4 25 | — | $15.6M | ||
| Q3 25 | — | $-8.0M | ||
| Q2 25 | — | $16.5M | ||
| Q1 25 | — | $238.0K | ||
| Q4 24 | — | $61.0K | ||
| Q3 24 | $-35.5M | $-575.0K | ||
| Q2 24 | $-7.3M | $3.0M | ||
| Q1 24 | $53.8M | $20.4M |
自由现金流率ESPRRGP
| Q4 25 | — | 13.2% | ||
| Q3 25 | — | -6.6% | ||
| Q2 25 | — | 11.8% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | -68.7% | -0.4% | ||
| Q2 24 | -9.9% | 2.1% | ||
| Q1 24 | 39.0% | 13.5% |
资本支出强度ESPRRGP
| Q4 25 | 0.0% | 0.3% | ||
| Q3 25 | 0.0% | 0.1% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.0% | 0.3% | ||
| Q4 24 | 0.0% | 1.2% | ||
| Q3 24 | 0.3% | 0.2% | ||
| Q2 24 | 0.1% | 0.1% | ||
| Q1 24 | 0.1% | 0.1% |
现金转化率ESPRRGP
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.30× | ||
| Q1 24 | 0.88× | 8.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
RGP
| US | $93.7M | 80% |
| Non Us | $24.0M | 20% |
